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Abstract
The role of G-protein activation in cardiovascular disorders is well-known. G-protein 3 subunit (GNB3) C825T poly-
morphism is associated with increased intracellular signal transduction. We investigated the role of the variant in
plasma sodium and potassium concentrations and association with hypertension. 345 healthy controls and 455 pa-
tients with essential hypertension were enrolled. Plasma renin activity and aldosterone concentration were mea-
sured. The variant, typed by SNaPshot, was analyzed on an ABI Prism 3100 Genetic Analyzer and GeneScan. The
TT genotype and T allele were over-represented in the patients (p < 0.001, p < 0.0001). Multiple-logistic regression
disclosed that the risk of hypertension was significantly greater for TT (p < 0.0001, OR = 6.1, CI = 2.9-12.7). One-way
ANOVA revealed that hypertensive T-allele carriers (CT+TT), compared to non-carriers (CC), had a greater body
mass index (BMI), mean arterial pressure (MAP) and PAC (p = 0.01, p = 0.01, p < 0.0001, respectively); while the pa-
tients with 825TT risk genotype showed higher plasma sodium and lower potassium (p < 0.0001, each). The results
strongly emphasize, not only the role of C825T polymorphism by the induction of increased G-protein activity and en-
hancement of Na/h exchangers, but also the association with higher plasma sodium and lower potassium levels,
high BMI and susceptibility to hypertension.
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It is widely accepted that nearly all transmembrane
receptors,aswellasvariousvasoactive/growth-stimulating
factorsincardiovascularhomeostasisandperipheralvascu-
lar resistance, depend on G-proteins to regulate intracel-
lular signaling cascades (Siffert et al., 1995). An increased
activity of G-protein enhances the Na/h exchanger (NHE-
1) in almost 50% of the patients with Essential Hyperten-
sion(EH),givesevidenceoftheroleoftheseproteinsinthe
pathogenesis of essential hypertension (EH) (Siffert and
Düsing, 1995; Schunkert et al., 1998). The GNB3 C825T
polymorphism results in alternative splicing of exon 9 that
eliminates 41 amino acids in the protein, thereby associat-
ing with the expression of a novel splice-variant (G3-s)
thatcorrelateswithenhancedG-proteinactivation.Thishas
been investigated, in order to establish an association with
bloodpressure,hypertension,body-massindex,left-ventri-
cular hypertrophy and related phenotypes (Siffert, 1996;
Schunkert et al., 1998; Siffert et al., 1999b; Poch et al.,
2000). On recognizing the significance of GNB3 C825T
polymorphism in susceptibility to hypertension, we under-
took an association study with a case-control design. Since
alterations in electrolyte balance can be through increased
G-proteinactivity,thenextstepwastoevaluateassociation
of the variant with plasma-sodium and potassium concen-
trations.
The study was approved by the ethical committee.
Each of the subjects involved signed an informed consent
form. Study subjects consisted of 345 consecutive unre-
lated sex-matched healthy controls and 455 EH patients, so
diagnosed through Hypertension outpatient clinics of col-
laborating hospitals. Details of selection criteria have al-
ready been presented in an earlier work (Nejatizadeh et al.,
2008). No exercise, alcohol, caffeine or smoking was
allowed,foraperiodof30minpriortoblood-pressuremea-
surement. Blood pressure (BP) was measured by conven-
tional mercury sphygmomanometer. Measurements by two
different observers were taken at the left arm in the seated
position after 15 min of rest. This procedure was repeated
three times, systolic BP (SBP) and diastolic BP (DBP) be-
ing defined as the mean of the three independent measure-
ments. According to the JNC VII panel, hypertension was
defined as an average SBP of  140 mm Hg, an average
DBP of  90 mm Hg (or both), or as a diagnosis of hyper-
tension in subjects receiving antihypertensive medication.
Demographic data were collected by means of a detailed
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Short Communicationstandardquestionnaire.Therewasalsoadetailedinterview,
physical examination and laboratory analysis. Blood sam-
ples were collected after 12 h overnight fasting. Cells were
used for DNA extraction and plasma for biochemical anal-
ysis.Thelatterwasstoredat-80°Cifnotanalyzedimmedi-
ately. GNB3 C825T polymorphism was genotyped, and the
effect of the genetic variant on clinical and biochemical pa-
rameters monitored in both study groups. Plasma renin ac-
tivity (PRA) and plasma aldosterone concentration (PAC)
were measured by radioimmunoassay (M/s Immunotech,
France). The counts were measured in duplicate on a gam-
ma counter (Ria Calc WIZARD 1470, USA). The variant
was typed by an SNaPshot ddNTP Primer Extension Kit
(Applied Biosystems, Foster City, Calif), electrophoresed
on an ABI Prism 3100 Genetic Analyzer (Applied Bio-
systems), and subsequently analyzed on an ABI Prism
GeneScan and Genotyper (Applied Biosystems). Sodium,
calcium, potassium, total cholesterol, triglyceride, uric
acid, creatinine, and glucose, were all measured on a high-
throughput autoanalyzer (Elecsys 2010, Roche, Germany).
Estimates were obtained in duplicate. Intra- and inter-assay
coefficients of variation were less than 5%. All statistical
analyses were carried out with SPSS 12.0 (SPSS Inc., Chi-
cago, Illinois, USA), and EPIINFO v. 6 softwares. Hardy-
Weinberg equilibrium (HWE) with 1 df a goodness of fit
test was calculated using the DeFinetti program. Allele and
genotype frequencies were estimated by gene counting.
Categorical and continuous variables were compared using

2-test and unpaired Student’s t-test. Logistic regression
analysis was undertaken with different models. Odds ratio
(OR)wascalculatedthroughlogisticregression.Whereap-
propriate,correctionformultipletestingwasmadebyBon-
ferroni correction test. Power calculations were performed
with the PS: Power and Sample Size Calculation program
by Dupont and Plummer. A two-tailed p value of < 0.05
was considered statistically significant.
The overall percentage of successful genotyping was
at least 99,4%. Genotype distribution was at Hardy-Wein-
berg equilibrium (p = NS). As the TT genotype was over-
representedinthepatients(LRT
2=16.2,df=2,p<0.001,
Table 1), consequently, the T allele was also
(LRT
2 = 25.9, df = 1, p < 0.0001). Multiple-logistic re-
gression analysis revealed that the risk of hypertension was
significantly higher for the TT genotype (p < 0.0001,
OR = 6.1, Wald’s 95% CI = 2.9-12.7) (Table 1). Signifi-
cancewasmaintainedevenafteradjustmentbyage,sexand
BMI(p<0.001).Significantprobabilityvaluesandrelative
risks for C825T polymorphism were obtained by imple-
menting recessive (p < 0.0001, OR = 5.0, Wald’s 95%
CI = 2.4-10.2) and additive models (p < 0.0001, OR = 5.0,
Wald’s 95% CI = 2.9-8.4). Homozygous 825T allele carri-
ersshowedconsiderablerelativerisk,withasix-foldhigher
chance of developing hypertension compared to homozy-
gous 825C allele carriers. One-way ANOVA revealed that
inhypertensiveT-allelecarriers(CT+TT),BMI,meanarte-
rial pressure (MAP) and PAC were higher (p = 0.01,
p = 0.01, p < 0.0001, respectively), when compared to non-
carriers (CC) (Table 1), whereas patients with the 825TT
risk genotype had higher plasma sodium, serum creatinine
and urea, and lower potassium levels (p < 0.0001, each)
(Table 2). In an association of the 825T allele with MAP
and PAC, increased plasma sodium and decreased potas-
sium concentrations were observed (p < 0.0001, each).
Worthy of note, our study revealed for the first time
an association among Asians of the 825T allele with MAP
and PAC, increased plasma sodium and decreased potas-
sium concentrations, which could reflect an enhanced ac-
tivity of NHE-1 in hypertension. Furthermore, the highly
significant PAC and low PRA in patients suggested of a
lowreninhypertension(Nejatizadehetal.,2008).Notwith-
standing, studies of ethnic groups are not devoid of conflict
(Beige et al., 1999; Brand et al., 1999; Larson et al., 2000;
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Table 1 - Distribution of alleles and genotype frequency of the GNB3 C825T polymorphism between patients and controls.
Genotypes Patients (n = 449) Controls (n = 345) OR
† 95%CI
‡ 
2 p*
CC 185 (41%) 192 (56%) -
CT 211 (47%) 144 (42%) 1.5 (1.1-2.0) 7.91 0.005
TT 53 (12%) 09 (02%) 6.1 (2.9-12.7) 28.4 0.0000
C 581 (65%) 528 (77%)
T 317 (35%) 162 (23%) 1.8 (1.4-2.2) 25.9 0.0000
HWE 
2 = 0.05, p = 0.97 
2 = 2.95, p = 0.22
Recessive model 5.0 (2.4-10.2) 22.9 0.0000
Dominant model 5.0 (0.4-0.7) 16.3 0.0000
Additive model 5.0 (2.9-8.4) 43.0 0.0000
†OR(CI%95),indicatescrudeoddsratioand95%confidenceinterval.
‡ORdenotesadjustedoddsratiobyage,sexandBMI.*pvaluesarecalculatedby
logisticregression.Numberoftheindividuals(%)Dominantmodelcomparesacombinationofheterozygousandhomozygousgenotypesoftheleastfre-
quentalleletohomozygotesofthemostfrequent.Recessivemodelcomparesacombinationofheterozygousandhomozygousgenotypesofthemostfre-
quentalleletothevariantallelehomozygousgenotype.Additivemodelcomparesacombinationofthetwogenotypeswithweight2and1respectivelyto
the homozygote of the most frequent allele.Staessen et al., 2003). Our findings are in accordance with
those of Siffert (2000). It is well-established that obesity,
salt retention and low plasma renin activity are associated
with NHE-1 hyperactivity (Delva et al., 1993; Diez et al.,
1995). As enhanced NHE-1 activity is subject to G-protein
hyperactivation in the presence of the 825T allele, a conse-
quential increase of these phenotypes in 825T allele carri-
ers is to be expected. Furthermore, the association of this
allele with obesity could not be overlooked, since BMI in
T-allele carriers (CT+TT) higher than in non-carriers (CC),
thus in agreement with an earlier report (Siffert et al.,
1999b). Although, G proteins are known to play a key role
in adipogenesis and 825T alleles predict enhanced G pro-
tein activation, the association between 825T allele and
obesity cannot attenuate the influence of non-genetic fac-
tors, such as life-style, for a susceptibility gene to present
its effect on obesity. Predictably, the 825T allele increases
theriskofobesity,which,overtheyears,leadstohyperten-
sion.
Moreover, given the causative nature of the C825T
variant,itislikelythatthevasoconstrictors,norepinephrine
and angiotensin II, also transmit their effect to pertussis
toxin-sensitiveGproteins,which,inturn,enhancevascular
resistance in individuals carrying mutated GNB3 proteins.
It is known that angiotensin II, as a main stimulator of
aldosterone, can act via Gi proteins, thereby enhancing
phospholipase C activity, cytosolic calcium liberation, and
CYP11B2 gene expression (Lu et al., 1996). Therefore, in
brief, in hypertensive TT carriers, lower angiotensin II lev-
els are regulated by increased postreceptor signaling and
subsequent high aldosterone and suppressed renin levels,
thus emphasizing 825T allele efficacy for enhancing intra-
cellular signal transduction in humans. In conclusion, our
results strongly suggest the contribution of GNB3 C825T
polymorphism to the risk of essential hypertension and
high BMI, and also highlight the role of increased Na
+-H
+
exchanger activity. Of course, it is likely that this associa-
tion could have arisen from a direct physiological effect of
the genetic variation or linkage disequilibrium, with an ad-
ditional functional alteration at the GNB3 locus. Nonethe-
less, validation of the functionality of the 825T allele,
nonetheless, is desirable, as a means of establishing its
causative role. Moreover, the role of other variants in or
near GNB3 cannot be overlooked. The identification and
functional significance of novel polymorphisms, such as A
(-350) G in the promoter region and A C1429T in the
3’-untranslated region of the GNB3, having occurred with
variable frequency in several ethnic groups, including
black Africans, Chinese, and Germans, have also been in-
vestigated (Rosskopf et al., 2000). Another assumption is
that GNB3 825T, possibly in concert with these and other
variants, influences variations in blood pressure and body-
weight. Additional work will be needed to elucidate the as-
sociations between these polymorphisms and G-protein
functions.
Interaction analysis of the GNB3 gene with other
genes involved in G protein-mediated pathways may be
helpful in developing an understanding of the association
between G protein-mediated pathways and cardiovascular
diseases. Despite universal recognition that blood pressure
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Table 2 - Anthropometric and demographic data in hypertensive patients according to 825C/T polymorphism of the GNB3 gene.
Parameter CC (n = 179) CT (n = 220) TT (n = 50) p* CT+TT (n = 270) p
†
Age, yr 50.1  11.6 52.6  12 51.8  9.1 0.1 52.2  10.5 0.05
Gender, % 58.1 58.6 62 0.83 60.3 0.77
BMI, kg/m
2 23.8  3.7 24.5  4.4 24.8  2.8 0.13 24.65  3.6 0.01
SBP, mmHg 168  18.2 169  18 171. 3  17 0.51 170  34.5 0.45
DBP, mmHg 99.4  8.4 100  10 102  8 0.21 101  9 0.04
MAP, mmHg 121  15.3 123  10 125  9 0.08 124  9.5 0.01
PP, mmHg 67.6  16 69.2  18 69  16 0.63 69.1  17 0.35
PAC, Pmole/L 155  41 220  62 255  6 < 0.0001 237.5  65 < 0.0001
Serum Na
+, mmol/L 135  7.8 137  6.6 142  7.2 < 0.0001 139.5  6.9 < 0.0001
Serum K
+, mmol/L 4.5  0.8 4.6  0.85 5.0  0.54 0.0005 4.8  0.69 0.00008
Serum creatinine, mg/dL 1.1  0.48 1.32  0.6 1.41  0.5 0.000002 1.36  0.55 < 0.0001
Serum urea, mg/dL 32  83 5  8.5 36.4  7.2 0.0001 35.7  7.85 0.000005
Total cholesterol, mg/dL 110  40 107  39 108  32 0.78 107.5  35 0.85
Triglyceride, mg/dL 100  30 105  35 90  25 0.1996  29 0.46
Uric acid, mg/dL 5.2  1.6 5.3  1.5 5.5  1.7 0.47  1.6 0.19
Values are mean  STD. BMI indicates body-mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; PP,
pulsepressure;Na
+,sodium;K
+,potassium;Ca
+,calcium.CC,CT,TT,andCT+TTrefertogenotypegroupsdescribedinthisstudy.*Statisticalanalysis
was performed by analysis of variance among the 3 genotypes.
†Statistical analysis was performed by Student’s t-test for CT +TT vs. CC genotypes.is influenced by interactions between the effects of several
geneticandenvironmentalfactors,thepossibilityofdetect-
ing statistically significant interactions between genetic ef-
fects measured by gene polymorphisms, and effects of
other genetic and environmental factors, have received
wideattention.Suchinteractionsmaygiverisetothediffer-
ent relationships between genotypic and phenotypic varia-
tions in diverse environments. Genotyping of these poly-
morphisms, along with a positive family history of
cardiovascular disease, could help in identifying individu-
als with high susceptibility to EH.
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